CAR T-Cell Therapy: New Hope for Remission in Leukemia

Gurpreet S. Lamba, MD   What are the main types of leukemia? How do they differ in terms of their effects, how they present and how they are treated? A. Leukemia is classified based on whether the malignancy originated from a lymphoid or myeloid white blood cell, and on how quickly the leukemia develops (i.e., … Continued

Targeting Treatments for Chronic Lymphocytic Leukemia

Dr. Joel Silver   How do myeloma and chronic lymphocytic leukemia (CLL) develop? What are some risk factors associated with those malignancies? A. We don’t know what causes CLL. We do know that people in some occupations or with a certain exposure history might be at higher risk, and that CLL generally affects older people. … Continued

Colorectal Cancer Trends in Maryland: A Conversation with Dr. Ralph V. Boccia

As the third most common cancer in the United States, colorectal cancer (CRC) affects about 1 in 20 Americans. However, incidence and death rates for cancer of the colorectum have significantly decreased over the past several decades as a result of increased screening and drastic improvements in treatment. In Maryland alone, approximately 70% of adults … Continued

Molecular Testing: Tailoring Treatment by Targeting Pathways

Phillip D. Reid, MD   What is molecular testing? How it is used in cancer care? A.  As we learn how to treat specific subtypes of cancer more accurately, molecular testing, molecular medicine and molecular diagnostics are becoming more prominent in oncology. In the past, once a cancer was diagnosed, we determined the organ where … Continued

Colorectal Cancer Trends and Treatment

Ralph V. Boccia, MD, a cancer specialist at RCCA Maryland, provides some insight into recent colorectal cancer trends and treatments that are giving new hope to doctors, researchers and patients nationwide. Overall, Dr. Boccia finds much to be encouraged by, but also points to the need for awareness of a concerning development in the field … Continued

RCCA Earns URAC Accreditation In Specialty Pharmacy

[Hackensack, NJ] – RCCA is proud to announce that it has earned URAC accreditation in Specialty Pharmacy. URAC is the independent leader in promoting healthcare quality through accreditation, certification and measurement. By achieving this status, RCCA has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.   “URAC Accreditation is a … Continued

RCCA Makes Innovative UnitedHealthcare Cancer Care Program Available to Patients in Maryland

HACKENSACK, N.J., Nov. 22, 2016 /PRNewswire-USNewswire/ — Regional Cancer Care Associates (RCCA) is expanding its cancer care payment initiative with UnitedHealthcare to RCCA patients in Maryland who are covered by UnitedHealthcare benefit plans. The program, made available at RCCA New Jersey locations in January, rewards physicians for focusing on best treatment practices, quality patient care and … Continued

RCCA: Taking Cancer Care To A Higher Level In NJ And Beyond

Edward J. Licitra, MD, PhD, board certified in internal medicine, hematology and medical oncology and chairman of the board of directors of Regional Cancer Care Associates (RCCA), shares some of his thoughts on potential models for a health care delivery reform system. Oncologists at RCCA, totaling 100 physicians, learn from each other’s best practices with … Continued